Periscope Capital’s Ibere Pharmaceuticals IBER Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-470,395
| Closed | -$4.75M | – | 911 |
|
|
2022
Q4 | $4.75M | Buy |
470,395
+14,225
| +3% | +$144K | 0.2% | 190 |
|
|
2022
Q3 | $4.52M | Buy |
456,170
+101,570
| +29% | +$1.01M | 0.13% | 314 |
|
|
2022
Q2 | $3.48M | Hold |
354,600
| – | – | 0.09% | 430 |
|
|
2022
Q1 | $3.48M | Buy |
354,600
+75,000
| +27% | +$736K | 0.09% | 446 |
|
|
2021
Q4 | $2.71M | Buy |
279,600
+249,600
| +832% | +$2.42M | 0.07% | 462 |
|
|
2021
Q3 | $291K | Hold |
30,000
| – | – | 0.01% | 603 |
|
|
2021
Q2 | $290K | Buy |
+30,000
| New | +$290K | 0.01% | 563 |
|